Oncocyte Corp Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Oncocyte Corp quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2021 to Q3 2024.
  • Oncocyte Corp Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 13.7M shares, a 66.1% increase year-over-year.
  • Oncocyte Corp annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 7.65M shares, a 38.1% increase from 2022.
  • Oncocyte Corp annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 5.54M shares, a 6130% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 13.7M +5.46M +66.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 12.9M +4.78M +59.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 8.26M +2.31M +38.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 7.65M +2.11M +38.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 8.26M +8.25M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 8.09M +8.08M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 5.96M -86.3M -93.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 5.54M +5.45M +6130% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 5.93K* -91.4M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 5.65K* -89.8M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 92.2M +10.1M +12.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 88.9K Oct 1, 2021 Dec 31, 2021 10-K 2023-04-12
Q3 2021 91.5M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 89.8M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 82.1M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.